Ionis extends losses as Roche scraps two partnered studies

PartnershipnegativeNegative

AI Analysis

Summary

Roche has terminated two clinical studies in partnership with Ionis Pharmaceuticals, extending losses for Ionis. This represents a significant setback to the collaborative program between the two companies.

Outcome Details

Roche scraps two partnered studies with Ionis

Importance:6/10

Sentiment:

-0.80

partnership_terminationclinical_trial_discontinuationnegative_catalyst

Related Companies

$IONS $RHHBY

Read the original article

Published by Seeking Alpha Healthcare on July 10, 2026 2:21 PM

Read Original